Table 3.

Safety outcomes

Toxicity	Prophylaxis patients N = 47, n (%)	Treatment patients N = 48, n (%)
Leucopenia
WBC count <3.5 × 109/L	8 (17); 8 SOT	27 (56); 7 SOT and 20 HSCT
WBC count >20% decrease from baseline	24 (51); 24 SOT	24 (50); 7 SOT and 17 HSCT
Thrombocytopenia
platelet count <100 × 109/L	17 (36); 17 SOT	31 (65); 3 SOT and 28 HSCT
platelet count >50% decrease from baseline	4 (9); 4 SOT	9 (19); 1 SOT and 8 HSCT

WBC count normal range = 4–10 × 10⁹/L.

Platelet count normal range = 150–400 × 10⁹/L.